Cardiovascular effects of sodium glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM), the leading type of diabetes, has a typical association with coronary heart disease. In India, patients with diabetes are at an increased risk of developing coronary disease as compared to people without diabetes and this suggests the requirement of intensive treatme...
Main Authors: | Surender Kumar, Pradeep G Talwalkar, Sambit Das, Soumik Goswami |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2019;volume=23;issue=1;spage=150;epage=158;aulast=Kumar |
Similar Items
-
Cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors in diabetic and nondiabetic patients
by: Boyang Xiang, et al.
Published: (2021-04-01) -
Cardiovascular effects and mechanisms of sodium-glucose cotransporter-2 inhibitors
by: Fan Yang, et al.
Published: (2020-12-01) -
How should we monitor the cardiovascular benefit of sodium–glucose cotransporter 2 inhibition?
by: Atsushi Tanaka, et al.
Published: (2020-12-01) -
Cardiovascular effects of sodium glucose cotransporter 2 inhibitors
by: Santos Cavaiola T, et al.
Published: (2018-04-01) -
Sodium-glucose co-transporter 2 inhibitors – a review article
by: Marcin Makuch, et al.
Published: (2019-08-01)